AmbioPharm To Utilize YMC Twin-Column Chromatography in Large Scale Peptide Production
AmbioPharm , a worldwide leader in peptide API CDMO services, announces the acquisition of new, disruptive, peptide purification technology developed by YMC which leverages several of YMC’s patented1 twin-column purification processes.
- AmbioPharm , a worldwide leader in peptide API CDMO services, announces the acquisition of new, disruptive, peptide purification technology developed by YMC which leverages several of YMC’s patented1 twin-column purification processes.
- Twin-column chromatography or Multicolumn Countercurrent Solvent Gradient Purification (MCSGP) is a continuous chromatographic process which collects a high purity center cut fraction and internally recycles mixed impurity/product-containing side fractions all while loading fresh feed and discarding impurities (see diagram).
- This press release features multimedia.
- View the full release here: https://www.businesswire.com/news/home/20230328005358/en/
This technology offers several advantages over traditional batch purification including: